Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer's disease.
暂无分享，去创建一个
R. Wahl | A. Cheng | R. Fremeau | D. Whittington | Yi Luo | D. Hickman | V. Patel | Kui Chen | S. Louie | Paul H. Wen | Stephen Wood | Hongbing Huang | O. Epstein | Y.-H. Kiang | D. La | Thomas A. Dineen | R. Graceffa | Stephen J. Wood